Open AccessImpact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus
Author(s) -
Christoph Stephan,
Annemarie Berger,
Amina Carlebach,
Thomas A. Lutz,
Markus Bickel,
Stephan Klauke,
Schlomo Staszewski,
M. Stuermer
Publication year - 2005
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dki396
Subject(s) - virology , medicine , chronic hepatitis , tenofovir , human immunodeficiency virus (hiv) , hepatitis b virus , cohort , antiretroviral therapy , virus , hepatitis b , viral disease , immunology , viral load
We studied the impact of tenofovir disoproxil fumarate, given as an antiretroviral medication, on patients with chronic hepatitis B virus (HBV) co-infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom